Worldwide Lung cancer and COPD market is measured to as of now be worth $11.3 billion, and is estimate to achieve an estimation of $15.6 billion by 2019. A current market research concentrate distributed by Transparency Market Research (TMR), the international asthma and COPD market was worth USD 25,102.3 million in 2010, which is relied upon to achieve USD 26,965.5 million in 2017 alongside a CAGR figure of 1.03% over the estimated by 2017.
According to a survey done by WHO, Chronic obstructive pulmonary disease will be the third leading cause of death world-wide causing considerable health costs, in 2020. Globally, it is assessed that 3 million deaths were caused by the COPD in 2015 (that is, 5% of all deaths comprehensively in that year). Over 90% of COPD deaths happen in low and middle-income countries.